ReviewWiley interdisciplinary reviews. RNA
MicroRNAs and Cancer Racial Disparities.
Review in Wiley interdisciplinary reviews. RNA. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- MicroRNAs in Salivary Gland Cancers Associated with Poor Prognosis: A Systematic Review.International journal of molecular sciences · 2026Pooled it
- Pooled it
- Expression of miR-92a and miR-125b and Their Association with Chemoradiotherapy Response in Locally Advanced Cervical Cancer.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer remains one of the leading causes of death worldwide. Despite various efforts to reduce cancer mortality, such as decreasing tobacco use, improving early detection and prevention methods, and enhancing cancer care and treatments, certain racial and ethnic groups continue to experience higher cancer incidence and mortality rates, along with shorter survival compared to other groups. Several factors, including socioeconomic status, environmental influences, diet, and behavior, contribute to these racial disparities. More importantly, scientists have identified a genetic basis for these observations, with a growing body of research highlighting microRNAs as significant players in cancer racial disparities. This review focuses on various types of microRNAs (such as epigenetically regulated, copy number altered, circulating, and exosomal) and microRNA single-nucleotide variations in the context of cancer-related racial disparities. Additionally, we have summarized the existing resources, including racial-specific model cell lines and cancer cohorts that include patients from diverse racial and ethnic backgrounds. Moreover, we provide here several key things to consider for future investigations. While many challenges remain, we aim to offer a balanced overview of this field to help scientists with varying expertise address these issues. This article is categorized under: RNA in Disease and Development > RNA in Disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.